474 filings
Page 6 of 24
4
tcbjovl
27 Jun 22
ANAPTYSBIO / ERIC J LOUMEAU ownership change
7:04pm
4
tpjnfdl
27 Jun 22
ANAPTYSBIO / Paul F. Lizzul ownership change
7:03pm
8-K
hs79k6asw55t59
24 Jun 22
Submission of Matters to a Vote of Security Holders
4:05pm
4
uo3r4o94x
10 Jun 22
ANAPTYSBIO / ERIC J LOUMEAU ownership change
5:22pm
4
x43sozfx 8b50bb894
20 May 22
ANAPTYSBIO / ERIC J LOUMEAU ownership change
4:42pm
SC 13G/A
68du2twghh woe
10 May 22
ANAPTYSBIO / FEDERATED HERMES ownership change
12:08pm
4
tse7rd7kl2ylgzibxym
9 May 22
ANAPTYSBIO / OLEG NODELMAN ownership change
6:04am
8-K
cqhp0fsh
4 May 22
AnaptysBio Announces First Quarter 2022 Financial Results and Provides Pipeline Update
4:19pm
DEFA14A
xxlxg76sqi1 zu
29 Apr 22
Additional proxy soliciting materials
5:00pm
8-K
ca7bbh
29 Apr 22
Departure of Directors or Certain Officers
4:06pm
8-K
wfti9y8
27 Apr 22
AnaptysBio Announces Positive ANB032 (anti-BTLA agonist) Top-Line Phase 1 Data and Provides Pipeline Updates
4:18pm
4
4rpllb
23 Mar 22
ANAPTYSBIO / Daniel Faga ownership change
4:48pm
8-K
82u26u8 ilzlpaxs1z5
21 Mar 22
Departure of Directors or Certain Officers
5:15pm
8-K
0kknhzhhwo69fnw
14 Mar 22
AnaptysBio Reports Imsidolimab ACORN Phase 2 Clinical Trial Data in Moderate-to-Severe Acne
4:26pm
S-8
91u5 83p543bzt
7 Mar 22
Registration of securities for employees
9:01am
8-K
icji9bg erj6
7 Mar 22
AnaptysBio Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Pipeline Update
8:53am
SC 13G/A
a3r831tjeh0ne
15 Feb 22
ANAPTYSBIO / PERCEPTIVE ADVISORS ownership change
12:00am